期刊文献+

活性炭对甘草酸二铵磷脂复合物注射液含量的影响

Effects of Activated Carbon on Content of Diammonium Glycyrrhizinate Phospholipid Complex Injection
下载PDF
导出
摘要 目的:考察活性炭对甘草酸二铵磷脂复合物(GPC)注射液生产工艺过程的影响,寻求最佳生产工艺。方法:通过正交设计考察加炭量、活性炭的加入方式、加热温度以及加热时间4个因素对药物含量的影响,采用L9(34)正交表进行了详细的考察。结果:正交试验结果表明,活性炭在加热前加入,加入量为0.05%,加热温度为80℃,加热时间为35m in时对药物的吸附量最少。结论:生产过程中应该对上述因素进行控制,以保证产品的质量。 Objective: To study the effects of activated carbon on content of diammonium glycyrrhizinate phospholipid complex injection. Methods: To arrange the test according to the L9 (3^4) orthogonal table, we selected four factors as dosage of activated carbon, the temperature of the solution, the time of heating, the adding method of activated carbon, each of which took three levels, and the content of diammonium glycyrrhizinate was chosen as the index. Results : The experiment results indicated that activate carbon significantly absorbed the diammonium glycyrrhizinate in solution. The optimum technique was that the dosage of activated carbon was 0.05%, the temperature was 80℃, the time of heating was 35min, adding the activated carbon before heating. Under this condition, the activate carbon showed the minimized absorbent in solution. Conclution: In ordor to enhance the quantity of the product, the above factors that affected the content of the Diammonium Glycyrrhizinate should be controlled during the preparation of the injection.
出处 《中华中医药学刊》 CAS 2009年第12期2615-2616,共2页 Chinese Archives of Traditional Chinese Medicine
基金 浙江省医药卫生科学计划资助项目(2005B142) 杭州市科技局项目(2005133838)
关键词 甘草酸二铵磷脂复合物 注射液 活性炭 正交设计 Diammonium glycyrrhizinate phospholipid compound injection activated carbon orthogonal design
  • 相关文献

参考文献3

二级参考文献26

  • 1黄能慧,李诚秀,任光友,李玲,罗俊,王世萍.甘草酸降血脂作用的实验研究[J].贵阳医学院学报,1994,19(4):333-335. 被引量:12
  • 2严瑞琪,李俊丽,黄玫玲,黄小延,王辉云,冯启胜.甘草甜素抑制致癌过程中对DNA损伤修复的影响[J].癌症,1995,14(4):245-248. 被引量:27
  • 3蔡宏伟,谭秀娟,王云姣,麻兴利,郭曲练,徐启明.甘草酸对缺血再灌注犬脑线粒体ATP酶活性的影响[J].中国药理学通报,1996,12(6):549-551. 被引量:13
  • 4王茂义,张华安,封卫毅,仉承涛,刘晓云.甘草酸铵霜的研究[J].中国药学杂志,1997,32(3):147-150. 被引量:13
  • 5[1]Van-RossumTG,VultOAG,HopWC,etal. Gly-cyrrhiZin-induced reduction of ALT in european patients with chronic hepatitis C.Am J Gastroenterol,2001,96(8):2432.
  • 6[3]Van-RossumTG,De-JongFH,HopWC,et al. Pseu-doaldosteronism′ induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients[J]. J Gastroen-terol Hepatol,2001,16(7):789
  • 7[5]Yi H, Nakashima I,Isobe. Enhancement of oxide production from activated macrophages by glycyrrhizin[J]. Am J chin Med, 1996,24(3-4):271.
  • 8[8]Nakajima N,Utsanomiya T, Kobayash M,et al. In vitro induction of anti-type-cells by glycyrrhizin[J].Burns,1996;22(8):612.
  • 9[9]Yoshiawa M,Matsui Y, Kawamoto H,et al. Effects of glycyrrhizinon immune-mediated cytotoxicity[J].Gastroenterol Hepatol. 1997; 12(3):243.
  • 10[11]Badam L. In vitro antiviral activity of indigenous glycyrrhiain[J].Commun Dis. 1997;29(2):91.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部